Newsletter Articles | June 30, 2001
U.S. Court Of Appeals Invalidates Prozac Patent
OPEN MINDS, The Behavioral Health & Social Service Industry Analyst
Industry News
On May 30, 2001, a three-judge panel of the U.S. Court of Appeals, Federal Circuit in Washington, D.C., reaffirmed its earlier decision invalidating the patent protecting Eli Lilly's Prozac antidepressant. The decision invalidates the patent that would have prevented generic competition prior to December 2003. After the ruling, Barr Laboratories said it expects to launch its generic 20 mg capsule product on August 3, 2001 at the expiration of Eli Lilly's pediatric exclusivity. </p . . .